A New York federal court on Thursday overturned a near $4.5 billion settlement which would have shielded members of the Sackler family who own Oxycontin maker Purdue Pharma from any future legal action relating to the opioid epidemic, in a decision that may upend the drugmaker’s bankruptcy reorganization plans. READ MORE: https://www.forbes.com/sites/siladityaray/2021/12/17/federal-court-overturns-purdue-pharma-settlement-that-shielded-sacklers-from-opioid-suits/?sh=40bf8ae06306 Stay Connected Forbes on Facebook: http://fb.com/forbes Forbes Video on Twitter: http://www.twitter.com/forbes Forbes Video on Instagram: http://instagram.com/forbes More From Forbes: http://forbes.com